125 related articles for article (PubMed ID: 15378007)
21. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors.
Alvarez JV; Febbo PG; Ramaswamy S; Loda M; Richardson A; Frank DA
Cancer Res; 2005 Jun; 65(12):5054-62. PubMed ID: 15958548
[TBL] [Abstract][Full Text] [Related]
22. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
[TBL] [Abstract][Full Text] [Related]
23. STAT3 can be activated through paracrine signaling in breast epithelial cells.
Lieblein JC; Ball S; Hutzen B; Sasser AK; Lin HJ; Huang TH; Hall BM; Lin J
BMC Cancer; 2008 Oct; 8():302. PubMed ID: 18939993
[TBL] [Abstract][Full Text] [Related]
24. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway.
Wang X; Merritt AJ; Seyfried J; Guo C; Papadakis ES; Finegan KG; Kayahara M; Dixon J; Boot-Handford RP; Cartwright EJ; Mayer U; Tournier C
Mol Cell Biol; 2005 Jan; 25(1):336-45. PubMed ID: 15601854
[TBL] [Abstract][Full Text] [Related]
25. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
26. Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells.
Konnikova L; Simeone MC; Kruger MM; Kotecki M; Cochran BH
Cancer Res; 2005 Aug; 65(15):6516-20. PubMed ID: 16061629
[TBL] [Abstract][Full Text] [Related]
27. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
28. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation.
Yang J; Chatterjee-Kishore M; Staugaitis SM; Nguyen H; Schlessinger K; Levy DE; Stark GR
Cancer Res; 2005 Feb; 65(3):939-47. PubMed ID: 15705894
[TBL] [Abstract][Full Text] [Related]
29. Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease.
Sato Y; Harada K; Kizawa K; Sanzen T; Furubo S; Yasoshima M; Ozaki S; Ishibashi M; Nakanuma Y
Am J Pathol; 2005 Jan; 166(1):49-60. PubMed ID: 15631999
[TBL] [Abstract][Full Text] [Related]
30. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
[TBL] [Abstract][Full Text] [Related]
33. Synergy between signal transducer and activator of transcription 3 and retinoic acid receptor-alpha in regulation of the surfactant protein B gene in the lung.
Yang L; Lian X; Cowen A; Xu H; Du H; Yan C
Mol Endocrinol; 2004 Jun; 18(6):1520-32. PubMed ID: 15044588
[TBL] [Abstract][Full Text] [Related]
34. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
[TBL] [Abstract][Full Text] [Related]
36. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
Gingras S; Moriggl R; Groner B; Simard J
Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
[TBL] [Abstract][Full Text] [Related]
37. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.
Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML
J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202
[TBL] [Abstract][Full Text] [Related]
38. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
Ma XT; Wang S; Ye YJ; Du RY; Cui ZR
Ai Zheng; 2003 Nov; 22(11):1135-9. PubMed ID: 14613639
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
[TBL] [Abstract][Full Text] [Related]
40. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]